Kurin, Inc. Announces the Launch of its Exclusive Push Button Needle System | Business

SAN DIEGO–(BUSINESS WIRE)–February 23, 2022–

Kurin, Inc., the inventor and manufacturer of Kurin ® blood culture collection sets, announced the commercial launch of its push-button needle, which will be used in Kurin blood culture sets. The Advance Safety Needle System was tested in 2021 and is now sold on accounts using Kurin.

“We are proud to bring the Advanced Safety Needle to market because there has been market demand for alternatives and improvements in this space,” said Bob Rogers, CEO of Kurin, Inc. “We are pleased with our field trials conducted over the past several months. In addition to the positive feedback we have received, our testing shows improved performance characteristics over traditional retraction-focused products. The development of the Advance Needle is a milestone important to Kurin, providing us with more reliable product supply, better cost control, the ability to offer greater benefits over current needles and creating new strategic opportunities in which we are already engaged.

Kurin’s revolutionary approach to the problem of contaminated blood culture is an elegant, simple and intuitive design that requires no additional steps from the user. Kurin passively brushes off potential contaminants when collecting blood cultures. Kurin is a simply better and more durable approach to conventional mechanical diversion. Contaminated blood cultures are a significant problem, as around a third of positive results are false, exposing these patients to unnecessary antibiotics, prolonging hospital stays and impacting broader community health issues, such as resistance. antimicrobials and life-threatening diseases. C.diff. infection.

About Kurin, Inc.

Kurin, Inc., a Certified Minority Business Enterprise (MBE), is focused on designing, developing, manufacturing, marketing and selling products that help healthcare providers reduce contaminated blood cultures. Kurin, manufactured in San Diego, Calif., has received 510(k) marketing clearance from the FDA. For more information about Kurin, visit the website at www.kurin.com.

Show source version on businesswire.com:https://www.businesswire.com/news/home/20220223005046/en/

CONTACT: Matt Heindel

Kurin, Inc.

858-752-9514

[email protected]

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA

INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES OTHER HEALTH OTHER SCIENCE GENERAL HEALTH BIOTECHNOLOGY

SOURCE: Kurin, Inc.

Copyright BusinessWire 2022.

PUBLISHED: 02/23/2022 06:00 AM/DISC: 02/23/2022 06:02 AM

http://www.businesswire.com/news/home/20220223005046/en

Copyright BusinessWire 2022.